Related Experiment Videos
Concomitant pulmonary valve replacement, VSD closure and coronary artery bypass surgery
M Zytowski1, A Sidiropoulos, J Liu
1Department of Cardiac Surgery, Charite, Humboldt University Berlin, Germany.
The Journal of Heart Valve Disease
|March 21, 1998
Summary
Surgery effectively treats adult pulmonary valve stenosis and coronary artery disease simultaneously. A stentless bioprosthesis and coronary artery bypass grafting yielded excellent outcomes in a complex case.
Area of Science:
- Cardiology
- Cardiac Surgery
- Adult Congenital Heart Disease
Background:
- Pulmonary valve stenosis (PVS) in adults often requires surgical intervention, especially with dysplastic valves.
- Percutaneous balloon valvulotomy is an alternative, but surgical management is preferred for specific valve morphologies.
- Concomitant coronary artery disease (CAD) adds complexity to the management of PVS.
Observation:
- A 50-year-old male presented with severe calcific PVS (peak-to-peak gradient 120 mmHg) and two-vessel CAD.
- Symptoms included dyspnea (NYHA class I-II) and angina pectoris (CCS class I-II).
- Intraoperative findings revealed an unexpected small ventricular septal defect (VSD) alongside the severe PVS.
Findings:
- The patient underwent successful simultaneous surgical correction.
- The VSD was closed, the pulmonary valve was replaced with a stentless bioprosthesis, and double coronary artery bypass grafting was performed.
- The postoperative recovery was uneventful.
Implications:
- Simultaneous surgical treatment of PVS and CAD in adults is feasible and yields excellent results.
- Stentless bioprostheses (xenografts) are a viable option for pulmonary valve replacement in this context.
- This approach offers a comprehensive solution for complex cardiac conditions in adult patients.